Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Phospholipid-nucleoside conjugates. 5. The interaction of selected 1-. beta. -D-arabinofuranosylcytosine-5'-diphosphate-L-1,2-diacylglycerols with serum lipoproteins

Journal Article · · Biochem. Biophys. Res. Commun.; (United States)
The phospholipid-nucleoside conjugates 1-..beta..-d-arabinofuranosylcytosine-5'-diphosphate-L-1,2-dipalmitin, -distearin, and -diolein have been shown to interact rapidly with canine high density lipoprotein and with both high density and low density lipoproteins isolated from human serum. The extent of interaction with the high density lipoproteins appears to be dependent upon the characteristic gel-liquid crystalline phase transition of the conjugate's phospholipid. Since the phospholipid-nucleoside conjugates under study represent sustained release forms of the antileukemic agent 1-..beta..-D-arabinofuranosylcytosine, the therapeutic efficacy of these conjugates should now be considered in light of these interactions.
Research Organization:
Argonne National Lab., IL
DOE Contract Number:
W-31109-ENG-38
OSTI ID:
5229489
Journal Information:
Biochem. Biophys. Res. Commun.; (United States), Journal Name: Biochem. Biophys. Res. Commun.; (United States) Vol. 116:2; ISSN BBRCA
Country of Publication:
United States
Language:
English